This is a U.S. news story, published by MSN, that relates primarily to COVID-19 news.
For more U.S. news, you can click here:
more U.S. newsFor more COVID-19 news, you can click here:
more COVID-19 newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
Novavax vaccines. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Novavax shot news, new mRNA vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novavax vaccineTime Magazine
•
84% Informative
Novavax’s COVID-19 vaccine is not approved by the FDA yet, but it is available in the U.S. under emergency use authorization, which the FDA issued to the company in July 2022 .
The new mRNA vaccines from Moderna and Pfizer -BioNTech have dominated the vaccine story.
All COVID-19 vaccines from the three manufacturers have been linked to an increased risk of inflammation of heart muscle, or pericarditis or myocarditis.
People receiving the Novavax vaccine may be reporting fewer events such as fever, muscle aches, and headaches compared to those receiving either mRNA vaccine.
VR Score
82
Informative language
79
Neutral language
67
Article tone
informal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
4
Affiliate links
no affiliate links